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OBJECTIVE — Widespreaduseofcarbohydratecountingislimitedbyitscomplexeducation.Inthis
study we compared a Diabetes Interactive Diary (DID) with standard carbohydrate counting in terms of
metabolic and weight control, time required for education, quality of life, and treatment satisfaction.
RESEARCH DESIGN AND METHODS — Adults with type 1 diabetes were randomly
assigned to DID (group A, n  67) or standard education (group B, n  63) and followed for
6 months. A subgroup also completed the SF-36 Health Survey (SF-36) and World Health
Organization-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ) at each visit.
RESULTS — Of 130 patients (aged 35.7  9.4 years; diabetes duration 16.5  10.5 years), 11
dropped out. Time for education was 6 h (range 2–15 h) in group A and 12 h (2.5–25 h) in group B
(P  0.07). A1C reduction was similar in both groups (group A from 8.2  0.8 to 7.8  0.8% and
groupBfrom8.40.7to7.91.1%;P0.68).NonsigniﬁcantdifferencesinfavorofgroupAwere
documented for fasting blood glucose and body weight. No severe hypoglycemic episode occurred.
WHO-DTSQscoresincreasedsigniﬁcantlymoreingroupA(from26.74.4to30.34.5)thanin
groupB(from27.54.8to28.65.1)(P0.04).RolePhysical,GeneralHealth,Vitality,andRole
Emotional SF-36 scores improved signiﬁcantly more in group A than in group B.
CONCLUSIONS — DID is at least as effective as traditional carbohydrate counting educa-
tion, allowing dietary freedom for a larger proportion of type 1 diabetic patients. DID is safe,
requires less time for education, and is associated with lower weight gain. DID signiﬁcantly
improved treatment satisfaction and several quality-of-life dimensions.
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T
here is universal consensus about
thelinkbetweentightglycemiccon-
trolandpreventionofdiabetescom-
plications. According to American
Diabetes Association recommendations
(1), good metabolic control can be
achieved not only by regular self-
monitoring of blood glucose and A1C
measurements but also through a system
by which nutritional care and the speciﬁc
lifestyle recommendations are provided,
involving patients in the decision-making
process(medicalnutritiontherapy).Aims
of medical nutrition therapy are to pro-
vide sufﬁcient and appropriate energy in-
take, to encourage healthy lifelong eating
habits, and to achieve and maintain the
best possible glycemic control and ideal
body weight (2). Several studies reported
that medical nutrition therapy and spe-
ciﬁc diet-related behaviors result in a de-
crease of 0.25–1.0% in A1C in patients
with diabetes (3–5).
In this context, carbohydrate count-
ing education represents a key point (6).
Carbohydrate counting consists of esti-
mating the grams of carbohydrate in
foods being eaten and relating that esti-
mate to the insulin bolus dose. The
method does not designate a speciﬁc per-
centage of energy as carbohydrate, but
carbohydrate intake is based on individ-
ual preferences, diabetes medication, and
maintenance of energy balance. The only
caveat is to not exceed energy require-
ments to avoid undesired weight gain
(6–8).
A ﬂexible carbohydrate intake is im-
mediatelytranslatedintoaﬂexibleinsulin
therapy (7), in which bolus insulin is ad-
justed to match the dietary carbohydrate
at each meal, identifying the most appro-
priate dose needed by the patient. Previ-
ous studies indicated that carbohydrate
counting and insulin dose adjustment at
eachmealpromotedietaryfreedom,qual-
ity of life, and glycemic control, without
worsening severe hypoglycemia or car-
diovascular risk (9).
However, it is clear that ﬂexible diet
and insulin therapy require complex
training for patients, who need to be ed-
ucated in the type and amount of carbo-
hydrate found in foods, portion
estimation, glycemic index, relationships
among blood glucose levels and food, di-
abetes medication, and physical activity,
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ciﬁc algorithms to adjust insulin doses
(6,7). The complexity of this educational
approach limits widespread use of carbo-
hydrate counting as an effective strategy
to promote dietary freedom, quality of
life, and glycemic control.
New advanced technologies repre-
sent a possible solution to overcome the
complex educational requirement. Data
availablesofarshowthattelemedicineso-
lutions for diabetes care are feasible and
acceptable, but their effectiveness in im-
proving A1C, reducing costs while main-
taining A1C levels, or improving other
aspects of diabetes management is not
fully clariﬁed because of methodological
ﬂaws in study design (10,11).
Among the new devices, the Diabetes
Interactive Diary (DID) represents an au-
tomaticcarbohydrate/insulinboluscalcu-
latortobeinstalledinthemobilephoneof
thepatient;italsoworksasatelemedicine
system based on patient-physician com-
munication via short text messages. Fea-
sibility, acceptability, and safety of the
DID have been already documented in a
phase 1 study (12). We designed a ran-
domized trial aiming to evaluate whether
DID could be effective in improving met-
abolic control in type 1 diabetes, while
avoiding weight gain and reducing time
devoted to education. In addition, in this
study we investigated whether and to
what extent DID could affect quality of
life.
RESEARCH DESIGN AND
METHODS
DID system
The DID is a new tool incorporating dif-
ferent functions; it is a carbohydrate/
insulin bolus calculator, an information
technology device, and a telemedicine
system based on the communication be-
tween a health care professional (physi-
cian or dietitian) and a patient via text
messages. It allows patients to manage a
ﬂexible diet and to calculate the matching
insulin bolus at each meal. In addition, it
includes an algorithm for the calculation
of basal insulin dose, based on the values of
fasting blood glucose and the presence of
hypoglycemic episodes.
DID consists of software to be in-
stalled in the patient’s mobile telephone
and enables the phone to be used as a
small computer to record the blood glu-
cose values and dose of insulin injections
in real time; the system is also able to sug-
gest the daily carbohydrate intake, sum-
ming the amount of carbohydrate
consumed progressively (Fig. 1). Every
patient can decide what to eat during the
meal, choosing between all the foods
listedinthesoftware;thequantiﬁcationof
the total calories and carbohydrate con-
sumed is facilitated by a list of pictures
showingthespeciﬁcfoodandtheamount
ingested. The carbohydrate-to-insulin ra-
tio and the glycemic correction factor,
identiﬁed and prescribed by the health
care professional, together with other in-
formation already ﬁlled out in the DID
(e.g.,physicalactivity,glycemictarget,in-
sulindose,andspeciﬁcevents),allowitto
automatically calculate and suggest the
Figure 1—Study ﬂow chart.
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injected.
Besides the collection of data on
blood glucose measurements, carbohy-
drate intake, and insulin doses, the use of
DID is associated with regular feedback
for the patient. In fact, data stored in the
mobile phone are periodically sent as
short text messages and reviewed on the
personal computer of the physician.
Then, any new therapeutic and behav-
ioral prescription can be sent from the
computer to the mobile phone, improv-
ing the communication between patients
and physician.
Study design and outcomes
The DID study was an open-label, inter-
national, multicenter, randomized (1:1),
parallel-group study, having the primary
goal of evaluating whether the use of DID
could improve glycemic control (A1C) in
a shorter time and more easily than the
carbohydrate counting standard educa-
tional approach. Secondary end points
were changes in fasting blood glucose
(FBG) levels, body weight, lipid proﬁle
(serumtotalcholesterol,HDLcholesterol,
LDL cholesterol, and triglycerides), and
blood pressure; furthermore, safety-
related problems (frequency of hypogly-
cemic episodes and hospitalizations) and
differences in time dedicated to educa-
tional activities were taken into consider-
ation. Finally, quality of life and patient
treatment satisfaction were investigated
in the subgroup of Italian patients. Data
were collected at baseline and at 3 and 6
months after the randomization. The
studyinvolvedsevenDiabetesOutpatient
Clinics:threeinItaly,twoinEngland,and
two in Spain. All of the centers habitually
provided carbohydrate-counting educa-
tion and used electronic databases.
Participants
Every center was asked to enroll 20 pa-
tients satisfying all of the following inclu-
sion criteria: diagnosis of type 1 diabetes,
age 18 years, no previous education on
carbohydrate counting, and treatment
with multiple daily injections of short-
acting and long-acting insulin analogs or
withcontinuoussubcutaneousinsulinin-
fusion; patients practiced self-monitoring
ofbloodglucoseatleastthreetimesaday.
Other important requirements in the se-
lectionofpatientswereadequatefamiliar-
ityintheuseofmobilephones,according
to the physician judgment, and posses-
sion of a personal mobile phone card. All
of the patients were requested to give
writteninformedconsenttogainentrance
to the study. Patients were excluded if
they were being treated with NPH insulin
or soluble regular insulin, had an eating
disorder, were pregnant, were unable to
send or receive short text messages, were
unableorunwillingtogiveinformedcon-
sent, or had any other disease or condi-
tion that may interfere with compliance
with the protocol or completion of the
study.
Randomization
Eligible patients were randomly assigned
to start the standard carbohydrate count-
ing educational program or the DID ap-
proach. Randomization was performed
through a telephone call to the coordinat-
ingcenter.Randomlistswerestratiﬁedby
center. To ensure equal allocation rates
within centers, permuted block random-
ization was used.
Interventions
Patients randomly assigned to the exper-
imental group attended a course on the
use of DID lasting up to 2 weeks. The
coursewasprovidedasanoutpatientpro-
gram of three encounters with the physi-
cian and/or dietitian.
Patients randomly assigned to the
control group received the standard edu-
cationalapproachusuallyusedinthecen-
ter, lasting up to 3 months. Before the
start of the study, an investigators’ meet-
ing was organized to establish some fun-
damentalrulesintheeducationaltraining
and in the prescription of carbohydrate-
to-insulin ratio and the correction factor.
Data collection
At study entry (visit 0), at 3 months (visit
1),andat6months(visit2)clinicalinfor-
mation was collected on case report
forms. Baseline information included so-
ciodemographic (age, sex, and highest
level of school education reached) and
clinical characteristics (diabetes duration,
insulin therapy, presence and severity of
diabetes complications, comorbidities,
andconcomitanttreatments).Bloodpres-
sure, body weight, FBG, A1C, and lipid
proﬁle were measured at each visit. Each
of the local laboratories used standard
methods to measure these parameters.
Additional information was collected at
the end of the study, including the num-
ber of contacts between the patient and
the diabetes specialist (both short text
messages and ofﬁce visits) and any seri-
ous hypoglycemic episode requiring
medical intervention.
Changes in health-related quality of
life substudy
Changes in the health-related quality of
lifewereevaluatedinthesubgroupofItal-
ian patients, using generic (SF-36 Health
Survey [SF-36]) and diabetes-speciﬁc
(World Health Organization-Diabetes
Treatment Satisfaction Questionnaire
[WHO-DTSQ]) measures:
● The SF-36 is one of the most widely
used measures of health-related quality
of life and consists of 36 items covering
eightdimensions:physicalfunctioning,
role limitations caused by physical
health problems, bodily pain, general
health perception, vitality, social func-
tioning,rolelimitationscausedbyemo-
tional health problems, and mental
health (13). These eight domains may
be further aggregated into two sum-
mary measures: the physical compo-
nent summary measure and the mental
component summary measure (13).
These aggregated scores are trans-
formed to norm-based scores (50  10
mean  SD), with higher scores indi-
cating more favorable physical func-
tioning/psychological well-being. The
SF-36 has been used in large popula-
tion studies and in many different clin-
ical conditions, showing excellent
psychometric properties (14). It has
been translated and validated in several
languages, including Italian (15).
● The WHO-DTSQ has been speciﬁcally
designed to measure satisfaction with
diabetes treatment regimens and is ap-
propriate for patients with type 1 and
type 2 diabetes (16). The instrument
was originally developed to detect
changes in satisfaction related to
changes in treatment modalities, but it
is also appropriate for comparing levels
of satisfaction in subjects using differ-
ent treatment regimens. It is composed
ofeightitems,sixofwhicharesummed
in a single score ranging from 0 (very
dissatisﬁed) to 36 (very satisﬁed). The
remaining two items are treated in-
dividually and explore the perceived
frequency of hyperglycemic and hypo-
glycemic episodes. The WHO-DTSQ
has been validated in the Italian lan-
guageamongtype1andtype2diabetic
patients, showing adequate psycho-
metric properties (17).
Statistical analysis
Sample size was estimated by assuming a
between-group mean difference of 0.5%
in A1C levels after 3 months and an A1C
Rossi and Associates
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study). Given these assumptions, 63 pa-
tients per group were needed to ensure a
statistical power of 80% (0.05). Tak-
ing into account a dropout rate of 10%,
70 patients per group had to be enrolled.
Analysiswasbasedonallthepatientsran-
domized, according to the intention-to-
treat principle. For patients lost to
follow-up the last information available
wasused,bymeansofthelastobservation
carriedforwardapproach.Comparisonof
A1C and other secondary end points be-
tweengroupswasperformedafter3and6
months from randomization based on the
Mann-Whitney U test. Within-group dif-
ferences achieved after 3 and 6 months
fromrandomizationwereevaluatedusing
the Wilcoxon signed-rank test. Because it
was hypothesized that the telemedicine
approach could help in achieving the de-
sired goals in a shorter period of time,
between-groups mean differences at 3
and 6 months were compared separately,
instead of using repeated-measures
ANOVA.
RESULTS— Overall, 130 individuals
were recruited (Fig. 1). Fewer patients
than those scheduled (130 vs. 140) were
involved, as a result of organizational
problems in two centers. However, be-
cause results show a SD of A1C of 0.76%
and the dropout rate was 8.5%, the a pos-
teriori study power to detect a difference
betweengroupsof0.5%inA1Clevelswas
95%. The study also had a statistical
power of 80% to detect a between-groups
difference in A1C levels of 0.38%.
Patients’ characteristics according to
the randomization arm are shown in Ta-
ble 1. The two groups did not differ for
any sociodemographic and clinical char-
acteristic, with the exception of slightly
higher levels of triglycerides in the DID
group. Patients in the DID arm also had a
higher prevalence of retinopathy and
symptomatic neuropathy, although sta-
tistical signiﬁcance was not reached.
Overall,11patientsdroppedoutdur-
ingthestudy,2inthestandardgroupand
9 in the DID group (Fig. 1). In the control
group, both patients were lost to follow-
up. In the DID group, 2 patients found it
difﬁcult to use the DID system, 4 had dif-
ﬁcultiesinsendingtextmessagesbecause
of poor mobile network coverage in
their area, 2 were not compliant with
visit scheduling, and 1 moved to an-
other area. Between- and within-group
changes after 3 and 6 months are shown
in Table 2.
A signiﬁcant reduction in A1C levels
of 0.5% was documented in both
groups after 3 months and maintained
until the end of study. This improvement
in metabolic control was obtained by de-
voting to carbohydrate counting educa-
tion a median (range) of 6 (2–15) h in the
DID group and 12 (2.5–25) h in the stan-
dard group (P  0.07). Furthermore, af-
ter 6 months there was a nonsigniﬁcant
decrease in FBG in the DID group (from
182.885.6to162.967.0mg/dl)and
a nonsigniﬁcant increase in the standard
group (from 176.9  68.4 to 186.3 
79.1 mg/dl) (between-groups P  0.13).
The increase in body weight was lower
intheDIDgroup(0.73.6kg)thaninthe
standard group (1.5  2.3 kg), but the
difference was not statistically signiﬁcant
(P  0.22). Furthermore, although we
found no differences in mean daily doses
of short-acting insulin between the two
groups (DID group 20.6  8.2 IU/day
and standard group 20.1  7.8 IU/day;
P  0.92), mean daily doses of long-
acting insulin were lower in the DID
group than in the standard group, al-
though statistical signiﬁcance was not
reached (DID group 17.4  7.4 IU/day
and standard group 21.4  10.0 IU/day;
P  0.12). The DID group showed a sig-
niﬁcant decrease in triglyceride levels in
comparison with the standard group; no
other between-groups changes were
documented.
Within-group changes were also con-
sidered.TheDIDgroupgenerallyshowed
a tendency toward a small, not signiﬁcant
improvement in all the measures consid-
ered, whereas in the standard group all
parameters, except diastolic blood pres-
sure and HDL cholesterol, tended to
slightly increase at the end of the study.
No patients in either group were ad-
mitted to the hospital during the study,
and none reported any severe hypoglyce-
mic episode requiring assistance. In each
group, two patients reported episodes of
mild hypoglycemia (P  0.93).
The median (range) number of text
messages sent by each patient during the
study was 52 (6–75), whereas the num-
ber of text messages sent by the physician
was 39 (22–70). In other words, patients
sent about 2 text messages/week to their
physician, and the physician regularly re-
Table 1—Patients’ characteristics according to the randomization arm
DID Standard P*
n 67 63
Male sex (%) 44.8 41.0 0.67
Age (years) 35.4  9.5 36.1  9.4 0.63
Highest level of school education completed (%) 0.23
Low level (less than college degree) 18.8 17.7
Intermediate level (less than university
degree) 68.7 58.1
High level (university degree) 12.5 24.2
Duration 17.1  10.3 15.8  10.7 0.37
Short-acting and/or long-acting analogs (%) 80.6 80.9 0.96
Continuous subcutaneous insulin infusion (%) 19.4 19.1 0.96
Self-monitoring (years) 14.7  7.3 13.2  8.4 0.10
No. of daily blood glucose tests 2.3  1.1 2.4  1.1 0.77
A1C (%) 8.2  0.8 8.4  0.7 0.19
Fasting glucose (mg(dl) 183  86 177  68 0.62
Systolic blood pressure (mmHg) 122  17 120  11 0.50
Diastolic blood pressure (mmHg) 74  77 4  8 0.72
Weight (kg) 69.9  12 69.4  11.9 0.98
Total cholesterol (mg/dl) 180  30 184  34 0.40
Triglycerides (mg/dl) 95  55 80  54 0.03
HDL cholesterol (mg/dl) 58  15 61  16 0.15
LDL cholesterol (mg/dl) 102  28 106  27 0.37
Retinopathy (%) 28.8 20.6 0.28
Lower-limb complications (%) 0 1.6 0.34
Nephropathy (%) 4.6 3.2 0.67
Symptomatic neuropathy (%) 9.1 3.2 0.17
Data are means  SD or frequency. *P values refer to the 
2 test for categorical variables or the Mann-
Whitney U test for continuous variables.
Telemedicine system in type 1 diabetes
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ortomodifytheparameterssetintheDID
(carbohydrate-to-insulin ratio, insulin
sensitivity factor, and/or blood glucose
target). In terms of costs for the patient,
assumingacostof10–15€centspermes-
sage, and considering that on average
each patient sent 52 messages, the overall
cost sustained did not exceed €8.
Results of quality of life evaluation
performed on the subsample of 60 pa-
tients enrolled in the Italian centers are
shown in Table 2. Clinical and sociode-
mographic characteristics at baseline did
not differ between the two groups. A sta-
tistically signiﬁcant difference in favor of
the DID group was documented for treat-
ment satisfaction, as expressed by the
WHO-DTSQ score. Similarly, the score
testing the perceived frequency of hyper-
glycemic episodes signiﬁcantly decreased
after 3 months in the DID group but not
in the control group. Several SF-36 sub-
scales (Role Physical, General Health, Vi-
tality, and Role Emotional) also showed
signiﬁcantly higher improvements in the
DID group than in the standard group.
In addition, pre– to post–within-
group comparisons underlined the bene-
ﬁcial effects of DID in the experimental
group in terms of WHO-DSTQ-score,
perceivedfrequencyofhyperglycemicep-
isodes, general health perception, and vi-
tality; on the other hand, all scores within
the standard group tended to worsen at 3
months, although statistical signiﬁcance
was not reached.
CONCLUSIONS — The complexity
of the educational approach needed to
teach carbohydrate counting and conse-
quent insulin adjustment can represent
an obstacle for many patients, thus limit-
ingthepossibilityofitswidespreaduseas
an effective self-management tool. The
carbohydrate/insulin bolus calculator is
coupledwithatelemedicinesystembased
on short text messages. At the present
time, the most common way of data com-
munication between patient and diabe-
tologist is represented by the paper diary,
which is often perceived as a boring doc-
ument not adequately ﬁlled in; further-
more, even if it is sufﬁciently complete, it
cannot facilitate a day-by-day adjustment
of the insulin dose and lifestyle (18). In
contrast, DID is installed on the mobile
phone, which is a familiar device already
used in daily life by the majority of indi-
viduals. DID facilitates not only the auto-
matic storage of blood glucose
measurements, carbohydrate intake, and
insulin doses but also the exchange of in-
formation between patient and care pro-
vider via text messages. In this respect,
although previous, small studies have
evaluatedtheefﬁcacyoftelemedicinesys-
tems based mainly on the transmission of
self-monitoring of blood glucose values
and feedback from the health care pro-
vider (10), this is, to our knowledge, the
ﬁrst study investigating a multipurpose
instrument, replacing the classic ap-
proach to insulin dose modiﬁcation.
OurdatashowthatDIDcanrepresent
a useful device, incorporating several fea-
tures helping patients promote dietary
freedom and ﬂexible insulin bolus. The
ﬁrst pilot study previously showed that
the system is safe, easy to use, and well
accepted by the vast majority of patients.
Whatthesenewresultsaddisthattheuse
of DID is at least as effective as the tradi-
tional educational approach to carbohy-
drate counting in reducing A1C levels,
while producing different concomitant
beneﬁts.First,itallowedpatientstoavoid
the complexities of carbohydrate count-
ing and insulin dose adjustment with a
halvinginthetimededicatedtoeducation
and thus potentially increasing the pro-
portion of individuals with type 1 diabe-
tesadoptingthismethod.Ofnote,despite
the higher rate of dropouts in the DID
group, only two patients interrupted the
study because of difﬁculties in using the
telecare system, thus conﬁrming that
the device can be easily used by the ma-
jority of patients.
Second,theuseofDIDwasassociated
with lower weight gain, probably because
oftherequirementoflowerdosesoflong-
acting insulin. It is worth mentioning
that, despite the use of lower doses of
long-acting insulin, patients assigned to
theDIDgroupshowedareductioninFPG
levels during the study, whereas levels
slightly increased in the control group.
This ﬁnding is important in light of the
need to adopt therapeutic strategies that
achieve good metabolic control while
minimizing insulin dosage.
Third, the use of DID was also associ-
ated with a signiﬁcant improvement in
several mental and physical components
of the SF-36 Health Survey, compared
with the standard group. This also trans-
latedintoamarkedimprovementintreat-
mentsatisfaction,thussuggestingthatthe
use of telemedicine can increase the level
of acceptance of insulin treatment and
help patients cope with the disease.
Somelimitationsofthisstudyneedto
be discussed. First, we were not able to
measuretheeffectofDIDinreducingglu-
cose variability. In fact, by allowing
greater ﬂexibility, one can speculate that
telemedicine produced positive effects on
postprandial blood glucose excursions
also. Second, even if speciﬁc guidelines
were established in the prestudy inves-
tigators’ meeting, the DID educational
intervention was inﬂuenced by the indi-
vidual practice of the different interna-
tional participating centers, thus varying
induration.Nevertheless,therandomiza-
tion was stratiﬁed by center, making the
comparison between telemedicine and
usual care unbiased.
Insummary,DIDwasatleastaseffec-
tive as traditional carbohydrate counting
education, allowing dietary freedom to a
larger proportion of type 1 diabetic pa-
tients. DID required less time for educa-
tion and did not increase the risk of
hypoglycemic episodes. DID also signiﬁ-
cantly improved treatment satisfaction
and several quality-of-life dimensions.
Larger studies are needed to reach more
solid conclusions regarding the effects of
DID on FBG, body weight, and insulin
dosage.
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APPENDIX— Participating centers
(in alphabetical order by town): Bourne-
mouthDorset,U.K.:DavidKerrandAnita
Bowes; Brescia, Italy: Angela Girelli,
Emanuela Zarra, and Antonino Cimino;
Coventry, U.K.: Antonio Ceriello, Anwar
Aresh, Lynda Dobson, and Lisa Walker;
Padua, Italy: Daniela Bruttomesso, Mich-
ela Dal Pos, and Silvana Costa; Ravenna,
Italy: Paolo Di Bartolo, Cipriana Sardu,
and Sara Brandolini; Sevilla, Spain: Angel
Sendon Perez and Carmen De la Cuesta
Mayor; and Valencia, Spain: Francisco
JavierAmpudiaandLaraSorribesQuerol.
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